ListarArtículos (Ingeniería Mecánica y de Fabricación) por materia "RANK-RANKL-OPG pathway"
Mostrando ítems 1-2 de 2
-
Artículo
Assessment of Strategies for Safe Drug Discontinuation and Transition of Denosumab Treatment in PMO—Insights From a Mechanistic PK/PD Model of Bone Turnover
(Frontiers Media S.A., 2022-06)Denosumab (Dmab) treatment against postmenopausal osteoporosis (PMO) has proven very efficient in increasing bone mineral ...
-
Artículo
Effects of long-term treatment of denosumab on bone mineral density: insights from an in-silico model of bone mineralization
(Elsevier, 2019)Denosumab is one of the most commonly prescribed anti-resorptive drugs for the treatment of postmenopausal osteoporosis. ...